
èŽåœçãªç§å¯: 2023幎åé ããã®COVID-19ã«ããæ»äº¡è ã®ãã¡ãã¯ã¯ãã³æªæ¥çš®è ã¯ããã5ïŒ ã ããã¯ã¯ãã³æ¥çš®è ã¯3-4åæ¥çš®è ã§95ïŒ ãå ãããšããè¡æçãªçµæ
å èšäºã¯ãã¡ããã/Click here to read the original article.
è±åœæ¿åºãã²ã£ãããšçºè¡šããå ±åæžã«ããã°ã2023幎ã«å ¥ã£ãŠããã®ã€ã³ã°ã©ã³ãã«ãããCOVID-19ã«ããæ»äº¡è ã®ãã¡ãã¯ã¯ãã³æªæ¥çš®è ãå ããå²åã¯ããã5ïŒ ã§ããã®ã«å¯Ÿããã¯ã¯ãã³3åæ¥çš®è ãš4åæ¥çš®è ã§ã¯COVID-19ã«ããæ»äº¡è ã®95ïŒ ãå ããŠããããã®å€§åã¯4åæ¥çš®è ã§èšé²ãããŠããããšãããCOVID-19泚å°ã®å¹æã¯ã»ã©é ãããšã確èªãããã
ç§ãã¡ãæãããçå®ã粟åçã«å ±éããåŸãè±åœæ¿åºã¯2022幎4æãè±åœä¿å¥æ©é¢ïŒUKHSAïŒã®é±éã¯ã¯ãã³ã»ãµãŒãã€ã©ã³ã¹ã»ã¬ããŒããããè±åœæ¿åºãç¡æã®æ®éçã³ãã-19æ€æ»ãäžæ¢ããããããŒã¿ãäžèŠã«ãªã£ããšããåç®ã§ããŒã¿ãé€å€ããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®ã³ãã-19æ»äº¡è æ°ãåœæ°ããé ãããšããã

ããããããŒã¿ãé ãããšããæ¬åœã®çç±ã¯ã2021幎7æä»¥éãCOVID-19ã«ããæ»äº¡ã®å€§åãã¯ã¯ãã³æ¥çš®è ãå ããŠãããCOVID-19ã¯ã¯ãã³ã®æå¹æ§ããã€ãã¹ã§ããããšãæ°åã§æããã«ãªã£ãããã§ããã
以äžã®ã°ã©ãã¯ã2022幎ã®ç¬¬3é±ã第7é±ã第13é±ã®ã¯ã¯ãã³ãµãŒãã€ã©ã³ã¹ã¬ããŒãã«ããããã€ã³ã°ã©ã³ãã®ããªãã«ã¯ã¯ãã³æ¥çš®è ã«ãããCOVID-19ã¯ã¯ãã³ã®æå¹æ§ã瀺ããŠããã

ããã¯ãã¡ã€ã¶ãŒç€Ÿã䞻匵ãã95ïŒ ã®æå¹æ§ã«ã¯ã»ã©é ãã®ã§ã¯ãªãã ãããïŒ
ããããè±åœæ¿åºã¯ããã®ããŒã¿ãå°æ¥ãåœå®¶çµ±èšå±ïŒONSïŒãçºè¡ããå ±åæžã§èŠã€ãããããããªããšããäºå®ãåœãŠã«ããŠããªãã£ããããšããç §åãšèšç®ã«éªšã®æããäœæ¥ãããããããšããŠãã
ææ°ã®ããŒã¿ã»ããã¯ãONSã®ãŠã§ããµã€ãã§èŠãããšãã§ããã
ãã®ããŒã¿ã»ããã«ã¯ã2021幎4æ1æ¥ãã2023幎5æ31æ¥ãŸã§ã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»äº¡è æ°ãå«ãŸããŠããã
ããããéå»ã«å ¬è¡šãããããŒã¿ã»ããã§ã¯2022幎æ«ãŸã§ã®æ»äº¡ãåºç¯å²ã«èª¿æ»ããŠããããã2023幎åé ããã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥Covid-19æ»äº¡ã調æ»ããããšã«ããã
ãã®çµæãå®ã«æãããããšãããã£ãã

ã¯ã¯ãã³æªæ¥çš®è ã¯2023幎5æãŸã§ã®ãã¹ãŠã®æã§COVID-19ã«ããæ»äº¡è æ°ãæãå°ãªããã»ãšãã©ã®æã§ãããããŠ3æ¡ã«ä¹ãçšåºŠã§ãã£ãã
äžæ¹ãã¯ã¯ãã³æ¥çš®è ã¯æ¯æCOVID-19ã«ããæ»äº¡è ã®å€§åãå ããŠããã5æãé€ããã¹ãŠã®æã§4æ¡ãèšé²ããŠããã
ãããããã®æ°åã§äžæè°ãªã®ã¯ã2023幎ã«å ¥ã£ãŠããã®COVID-19ã«ããæ»äº¡è æ°ã®å€§åãå ããŠããã®ãã1åæ¥çš®è ã§ã2åæ¥çš®è ã§ããªãããšã ã
代ããã«COVID-19ã«ããæ»äº¡è ã®å€§åãå ããŠããã®ã¯ã3åæ¥çš®è ãš4åæ¥çš®è ã§ããã
4皮混åã¯ã¯ãã³æ¥çš®è ãæãå€ãæ»äº¡ããŠããã
以äžã®ã°ã©ãã¯ã幎éãéããŠã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®COVID-19ã«ããæ»äº¡è æ°ã瀺ããŠãããã·ã§ããã³ã°ãªçµ±èšã®ççžãæããã«ããŠããã

ã¯ã¯ãã³æªæ¥çš®è ã¯4æ¡ã«ãå±ããã2023幎1æãã5æãŸã§ã®æ»äº¡è ã¯ããã436人ã ã£ãã
ããããã¯ã¯ãã³æ¥çš®è ã¯8,330人ã®COVID-19æ»äº¡è ã§ã»ãŒ5æ¡ã«éãããã®ãã¡1,032人ã¯3皮混åã¯ã¯ãã³æ¥çš®è ã6,902人ã¯4皮混åã¯ã¯ãã³æ¥çš®è ãšããè¡æçãªçµæã ã£ãã
ããã¯æ¬¡ã®ã°ã©ãã«ç€ºãããã«ã2023幎1æãã5æãŸã§ã®COVID-19ã«ããæ»äº¡è æ°ã®95ïŒ ãã¯ã¯ãã³æ¥çš®è ãå ããã¯ã¯ãã³æªæ¥çš®è ã¯ããã5ïŒ ã ã£ãããšãæå³ããã

ããããæ¬åœã«æãããã®ã¯ããããã®æ»äº¡è ã1åæ¥çš®è ãš2åæ¥çš®è ã®éã§ã¯ãªããšããäºå®ã§ããã倧倿°ã¯4åæ¥çš®è ã§ããã®éå£ã¯COVID-19ã«ããæ»äº¡è å šäœã®80ïŒ ãå ããã¯ã¯ãã³æ¥çš®è ã«ãããCOVID-19ã«ããæ»äº¡è å šäœã®83ïŒ ãå ããŠããã
ãããã3åæ¥çš®è ãš4åæ¥çš®è ãåããããšãCOVID-19ã«ããæ»äº¡è å šäœã®91ïŒ ãã¯ã¯ãã³æ¥çš®è ã«ãããCOVID-19ã«ããæ»äº¡è å šäœã®95ïŒ ã3åæ¥çš®è ãš4åæ¥çš®è ãå ããŠããããšããããã
COVID-19ã®æ³šå°ãæ¬åœã«æ»äº¡ã95ïŒ é²ã广ãããã®ãªãããã®ãããªæ°åã¯æåŸ ã§ããªãã®ã§ã¯ãªãã ãããïŒ
ãã®ãããªæ°åãèšé²ãããŠããã®ã«ãæ¿åºã¯ã©ãããŠCOVIDã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ãç¶ããããšãã§ããã®ã ãããïŒããæ³šå°ãå®å šã§å¹æçã§ããã°ãCOVID-19ã«ããæ»äº¡ã®95ïŒ ã¯ã¯ã¯ãã³æ¥çš®è ã§ã¯ãªããã¯ã¯ãã³æªæ¥çš®è ã®éã§èµ·ãã£ãŠããã¯ãã§ããã
ãããŠããããããã¢ã€ã¹ã©ã³ããããã§ããããã«ã圌ããCOVID-19ã®äœ¿çšãäžæ¢ãã¹ãçç±ãªã®ã ã